AAA

Affinity Asset Advisors Portfolio holdings

AUM $676M
1-Year Est. Return 29.75%
This Quarter Est. Return
1 Year Est. Return
+29.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$639M
AUM Growth
-$1.35M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
109
New
Increased
Reduced
Closed

Top Buys

1
+$16.8M
2
+$15.6M
3
+$13.1M
4
NUVL icon
Nuvalent
NUVL
+$12.4M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$11.9M

Top Sells

1
+$12.1M
2
+$10.3M
3
+$5.72M
4
ARWR icon
Arrowhead Research
ARWR
+$5.64M
5
SYRE icon
Spyre Therapeutics
SYRE
+$5.53M

Sector Composition

1 Healthcare 90.82%
2 Financials 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORKA
26
Oruka Therapeutics
ORKA
$1.34B
$5.6M 0.53%
545,362
+176,664
NBIX icon
27
Neurocrine Biosciences
NBIX
$15.2B
$5.53M 0.53%
+50,000
AVTX icon
28
Avalo Therapeutics
AVTX
$268M
$5.26M 0.5%
657,154
+106,389
VRDN icon
29
Viridian Therapeutics
VRDN
$2.62B
$5.26M 0.5%
390,000
+230,386
LXEO icon
30
Lexeo Therapeutics
LXEO
$598M
$5.14M 0.49%
+1,480,881
CRNX icon
31
Crinetics Pharmaceuticals
CRNX
$3.8B
$5.11M 0.49%
152,252
-307,748
RZLT icon
32
Rezolute
RZLT
$998M
$4.93M 0.47%
1,700,000
+125,000
CATX icon
33
Perspective Therapeutics
CATX
$163M
$4.74M 0.45%
2,224,196
+924,196
AUTL
34
Autolus Therapeutics
AUTL
$354M
$4.72M 0.45%
3,045,000
-1,455,000
ERAS icon
35
Erasca
ERAS
$644M
$4.58M 0.44%
3,341,519
+842,088
PRQR icon
36
ProQR Therapeutics
PRQR
$234M
$4.37M 0.42%
3,284,512
+459,512
QURE icon
37
uniQure
QURE
$1.71B
$4.24M 0.4%
+400,000
PCSC
38
Perceptive Capital Solutions
PCSC
$118M
$3.62M 0.35%
350,000
SLNO icon
39
Soleno Therapeutics
SLNO
$2.56B
$3.57M 0.34%
50,000
-80,000
INZY
40
DELISTED
Inozyme Pharma
INZY
$3.52M 0.34%
3,867,710
-104,608
AKBA icon
41
Akebia Therapeutics
AKBA
$541M
$2.88M 0.27%
+1,500,000
MAZE
42
Maze Therapeutics
MAZE
$1.38B
$2.75M 0.26%
+250,000
NAMSW icon
43
NewAmsterdam Pharma Warrant
NAMSW
$2.75M 0.26%
241,957
+4,022
KYMR icon
44
Kymera Therapeutics
KYMR
$4.22B
$2.74M 0.26%
100,000
+60,000
OACCU
45
Oaktree Acquisition Corp III Life Sciences Unit
OACCU
$2.6M 0.25%
250,000
GERN icon
46
Geron
GERN
$683M
$2.38M 0.23%
1,500,000
-750,000
MNPR icon
47
Monopar Therapeutics
MNPR
$499M
$2.26M 0.22%
+62,000
MIRM icon
48
Mirum Pharmaceuticals
MIRM
$3.5B
$2.24M 0.21%
49,692
-21,050
JBIO
49
Jade Biosciences
JBIO
$423M
$2.01M 0.19%
22,857
CGEM icon
50
Cullinan Oncology
CGEM
$425M
$2M 0.19%
263,817
1
2
3 4 5